Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionDearborn Partners Llc
Latest Disclosed Ownership69,875 shares
Latest Disclosed Value $ 9,738,444
Dearborn Partners Llc reports 3.71% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 12, 2026 - Dearborn Partners Llc filed a 13F-HR form disclosing ownership of 69,875 shares of Gilead Sciences, Inc. (CH:GILD) valued at $9,738,444 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 72,570 shares of Gilead Sciences, Inc.. This represents a change in shares of -3.71% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Gilead Sciences COM 375558103 69,875 -2,695 -3.71 9,738 9.33 0.5094
2026-02-11 2025-12-31 13F Gilead Sciences COM 375558103 72,570 -3,283 -4.33 8,907 5.80 0.4448
2025-11-10 2025-09-30 13F Gilead Sciences COM 375558103 75,853 -1,707 -2.20 8,420 -2.09 0.3948
2025-08-14 2025-06-30 13F Gilead Sciences COM 375558103 77,560 1,065 1.39 8,599 0.33 0.4071
2025-05-08 2025-03-31 13F Gilead Sciences COM 375558103 76,495 -13,906 -15.38 8,571 2.65 0.4115
2025-02-07 2024-12-31 13F Gilead Sciences COM 375558103 90,401 -228,724 -71.67 8,350 -68.79 0.3499
2024-11-06 2024-09-30 13F Gilead Sciences COM 375558103 319,125 -11,954 -3.61 26,755 17.79 1.0860
2024-07-26 2024-06-30 13F Gilead Sciences COM 375558103 331,079 -3,282 -0.98 22,715 -7.25 0.9822
2024-05-08 2024-03-31 13F Gilead Sciences COM 375558103 334,361 -102,882 -23.53 24,492 -30.86 1.0514
2024-01-26 2023-12-31 13F Gilead Sciences COM 375558103 437,243 -11,657 -2.60 35,421 5.29 1.2903
2023-11-01 2023-09-30 13F Gilead Sciences COM 375558103 448,900 4,498 1.01 33,641 -1.78 1.3201
2023-08-03 2023-06-30 13F Gilead Sciences COM 375558103 444,402 -7,399 -1.64 34,250 -8.63 1.3106
2023-05-04 2023-03-31 13F Gilead Sciences COM 375558103 451,801 -700 -0.15 37,486 -3.51 1.4746
2023-02-02 2022-12-31 13F Gilead Sciences COM 375558103 452,501 -1,846 -0.41 38,847 38.60 1.5679
2022-11-21 2022-09-30 13F/A-1 Gilead Sciences COM 375558103 454,347 12 0.00 28,029 -0.19 1.2363
2022-10-25 2022-09-30 13F Gilead Sciences COM 375558103 454,347 12 28,029 1.1556
2022-07-20 2022-06-30 13F Gilead Sciences COM 375558103 454,335 3,484 0.77 28,082 4.77 1.1861
2022-05-04 2022-03-31 13F Gilead Sciences COM 375558103 450,851 11,611 2.64 26,803 -15.96 1.0165
2022-01-28 2021-12-31 13F Gilead Sciences COM 375558103 439,240 -1,623 -0.37 31,893 3.57 1.1563
2021-10-27 2021-09-30 13F Gilead Sciences COM 375558103 440,863 2,067 0.47 30,794 1.92 1.2507
2021-07-26 2021-06-30 13F Gilead Sciences COM 375558103 438,796 2,343 0.54 30,215 7.12 1.2150
2021-04-29 2021-03-31 13F Gilead Sciences COM 375558103 436,453 22,217 5.36 28,208 16.89 1.2020
2021-01-27 2020-12-31 13F Gilead Sciences COM 375558103 414,236 3,065 0.75 24,133 -7.12 1.0986
2020-10-20 2020-09-30 13F Gilead Sciences COM 375558103 411,171 -421 -0.10 25,982 -17.96 1.2936
2020-07-30 2020-06-30 13F Gilead Sciences COM 375558103 411,592 58,904 16.70 31,668 20.10 1.7113
2020-05-11 2020-03-31 13F Gilead Sciences COM 375558103 352,688 9,538 2.78 26,367 18.25 1.6354
2020-01-28 2019-12-31 13F Gilead Sciences COM 375558103 343,150 27,363 8.67 22,298 11.41 1.1357
2019-10-29 2019-09-30 13F Gilead Sciences COM 375558103 315,787 29,926 10.47 20,015 3.63 1.1573
2019-07-29 2019-06-30 13F Gilead Sciences COM 375558103 285,861 10,294 3.74 19,313 7.80 1.1793
2019-05-01 2019-03-31 13F Gilead Sciences COM 375558103 275,567 16,984 6.57 17,915 10.76 1.1956
2019-02-04 2018-12-31 13F Gilead Sciences COM 375558103 258,583 -623 -0.24 16,175 -19.18 1.2497
2018-10-24 2018-09-30 13F Gilead Sciences COM 375558103 259,206 71,145 37.83 20,014 50.22 1.4020
2018-08-14 2018-06-30 13F Gilead Sciences COM 375558103 188,061 -5,052 -2.62 13,323 -8.49 1.0413
2018-05-01 2018-03-31 13F Gilead Sciences COM 375558103 193,113 -4,715 -2.38 14,559 2.73 1.1235
2018-02-02 2017-12-31 13F Gilead Sciences COM 375558103 197,828 -7,078 -3.45 14,172 -14.64 1.0204
2017-11-13 2017-09-30 13F Gilead Sciences COM 375558103 204,906 -12,321 -5.67 16,602 7.98 1.2215
2017-08-09 2017-06-30 13F Gilead Sciences COM 375558103 217,227 4,485 2.11 15,375 6.41 1.1360
2017-05-15 2017-03-31 13F Gilead Sciences COM 375558103 212,742 8,214 4.02 14,449 -1.35 1.1240
2017-01-26 2016-12-31 13F Gilead Sciences COM 375558103 204,528 3,088 1.53 14,646 -8.11 1.2244
2016-10-24 2016-09-30 13F Gilead Sciences COM 375558103 201,440 2,779 1.40 15,938 -3.83 1.3446
2016-07-18 2016-06-30 13F Gilead Sciences COM 375558103 198,661 15,761 8.62 16,572 -1.36 1.4379
2016-04-19 2016-03-31 13F Gilead Sciences COM 375558103 182,900 9,120 5.25 16,801 -4.46 1.5623
2016-01-21 2015-12-31 13F Gilead Sciences COM 375558103 173,780 81,664 88.65 17,585 94.42 1.6369
2015-10-19 2015-09-30 13F Gilead Sciences COM 375558103 92,116 -2,547 -2.69 9,045 -18.39 0.9064
2015-08-13 2015-06-30 13F Gilead Sciences COM 375558103 94,663 -14,210 -13.05 11,083 3.73 1.0684
2015-04-21 2015-03-31 13F Gilead Sciences COM 375558103 108,873 108,873 0.00 10,684 0.9341
2015-01-28 2014-12-31 13F Gilead Sciences COM 375558103 0 -76,887 -100.00 0 -100.00
2014-10-29 2014-09-30 13F Gilead Sciences COM 375558103 76,887 -6,347 -7.63 8,184 18.59 0.7924
2014-07-23 2014-06-30 13F Gilead Sciences COM 375558103 83,234 363 0.44 6,901 17.52 0.6768
2014-05-05 2014-03-31 13F Gilead Sciences COM 375558103 82,871 -5,374 -6.09 5,872 -11.39 0.6407
2014-02-14 2013-12-31 13F Gilead Sciences COM 375558103 88,245 -5,807 -6.17 6,627 12.08 0.7729
2013-10-24 2013-09-30 13F Gilead Sciences COM 375558103 94,052 375 0.40 5,913 23.11 0.7775
2013-07-22 2013-06-30 13F Gilead Sciences COM 375558103 93,677 93,677 4,803 0.6825
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.